ARL2BP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.224200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.579300E-03
Normal-vs-Stage2
2.282400E-01
Normal-vs-Stage3
3.382000E-01
Normal-vs-Stage4
8.835400E-01
Stage1-vs-Stage2
1.414800E-01
Stage1-vs-Stage3
8.574200E-01
Stage1-vs-Stage4
1.700310E-02
Stage2-vs-Stage3
7.957400E-01
Stage2-vs-Stage4
2.077000E-01
Stage3-vs-Stage4
3.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.053400E-01
Normal-vs-AfricanAmerican
4.101800E-01
Normal-vs-Asian
4.741900E-02
Caucasian-vs-AfricanAmerican
7.027200E-01
Caucasian-vs-Asian
1.105040E-01
AfricanAmerican-vs-Asian
2.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.299200E-01
Normal-vs-Female
2.098600E-01
Male-vs-Female
3.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.052170E-01
Normal-vs-Age(41-60Yrs)
4.459400E-01
Normal-vs-Age(61-80Yrs)
1.723030E-01
Normal-vs-Age(81-100Yrs)
5.696400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.638000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.735400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.598000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.141100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.790400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.805600E-02
Normal-vs-Daily Drinker
8.922400E-02
Normal-vs-Weekly Drinker
2.820600E-01
Normal-vs-Occasional Drinker
3.624400E-01
Normal-vs-Social Drinker
5.602800E-01
Non Drinker-vs-Daily Drinker
9.454200E-01
Non Drinker-vs-Weekly Drinker
2.640600E-01
Non Drinker-vs-Occasional Drinker
2.581200E-01
Non Drinker-vs-Social Drinker
3.246300E-02
Daily Drinker-vs-Weekly Drinker
3.050800E-01
Daily Drinker-vs-Occasional Drinker
3.111600E-01
Daily Drinker-vs-Social Drinker
4.422400E-02
Weekly Drinker-vs-Occasional Drinker
9.939200E-01
Weekly Drinker-vs-Social Drinker
3.790400E-01
Occasional Drinker-vs-Social Drinker
4.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.121200E-01
Normal-vs-Grade 2
5.706200E-01
Normal-vs-Grade 3
5.842800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.584400E-03
Grade 1-vs-Grade 3
4.431900E-02
Grade 1-vs-Grade 4
7.121200E-01
Grade 2-vs-Grade 3
7.388400E-01
Grade 2-vs-Grade 4
5.706200E-01
Grade 3-vs-Grade 4
5.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.571170E-01
Normal-vs-NonDiabetic
2.130200E-01
Diabetic-vs-NonDiabetic
2.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.058990E-01
Normal-vs-NoPancreatitis
2.297800E-01
Pancreatitis-vs-NoPancreatitis
9.314400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.113600E-01
Normal-vs-N1
2.526800E-01
N0-vs-N1
7.787800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.260000E-01
Normal-vs-TP53-NonMutant
2.554000E-01
TP53-Mutant-vs-TP53-NonMutant
4.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
